Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011
Open Access
- 27 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl 4) , S245-S249
Abstract
The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.Keywords
This publication has 48 references indexed in Scilit:
- World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource-Limited CountriesClinical Infectious Diseases, 2012
- Prevalence of Transmitted HIV Drug Resistance Among Newly Diagnosed Antiretroviral Therapy–Naive Pregnant Women in Lilongwe and Blantyre, MalawiClinical Infectious Diseases, 2012
- Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010Clinical Infectious Diseases, 2012
- Prevalence of HIV Drug Resistance Before and 1 Year After Treatment Initiation in 4 Sites in the Malawi Antiretroviral Treatment ProgramClinical Infectious Diseases, 2012
- Surveillance of Transmitted HIV Drug Resistance Using Matched Plasma and Dried Blood Spot Specimens From Voluntary Counseling and Testing Sites in Ho Chi Minh City, Vietnam, 2007–2008Clinical Infectious Diseases, 2012
- Surveillance of Transmitted HIV-1 Drug Resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005–2009Clinical Infectious Diseases, 2012
- Monitoring of Early Warning Indicators for HIV Drug Resistance in Antiretroviral Therapy Clinics in ZimbabweClinical Infectious Diseases, 2012
- Surveillance of Transmitted Drug-Resistant HIV Among Young Pregnant Women in Ouagadougou, Burkina FasoClinical Infectious Diseases, 2012
- Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory NetworkClinical Infectious Diseases, 2012
- HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational studyThe Lancet Infectious Diseases, 2011